Free tool
FAERS Monitor: Potassium Chloride 0.3% In Dextrose 5% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019699 or its brand name (Potassium Chloride 0.3% In Dextrose 5% In Plastic Container, Dextrose, Potassium Chloride). Reports on generic versions are filed under their own applications.
Reports
17
Serious
10
59% of reports
Hospitalization
10
Death reported
2
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- febrile neutropenia3
- renal ischaemia3
- anaemia2
- burkholderia test positive2
- covid-192
- endotracheal intubation2
- intercepted product selection error2
- malaise2
- product label confusion2
- product name confusion2
- pruritus2
- pyrexia2
- respiratory rate decreased2
- white blood cell count decreased2
- abdominal mass1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2007 | 1 |
| 2014 | 2 |
| 2016 | 3 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,142 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| burkholderia test positive | 2 | 20302.9 | 5456.9 | 22,470 |
| renal ischaemiaSignal | 3 | 6829.8 | 2437.5 | 14,146 |
| product name confusion | 2 | 2274.5 | 617.9 | 2,551 |
| intercepted product selection error | 2 | 1905.4 | 517.7 | 2,137 |
| endotracheal intubation | 2 | 883.4 | 240.2 | 990 |
| respiratory rate decreased | 2 | 788.3 | 214.3 | 883 |
| abdominal mass | 1 | 462.1 | 69.0 | 115 |
| product label confusion | 2 | 424.7 | 115.5 | 475 |
| febrile neutropeniaSignal | 3 | 56.0 | 20.0 | 112 |
| white blood cell count decreased | 2 | 22.8 | 6.2 | 23 |
| covid-19 | 2 | 14.1 | 3.8 | 13 |
| anaemia | 2 | 13.0 | 3.5 | 12 |
| pyrexia | 2 | 7.2 | 1.9 | 5 |
| pruritus | 2 | 6.4 | 1.8 | 5 |
| malaise | 2 | 5.6 | 1.5 | 4 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.